Clinical Trial Update: A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vortioxetine in Japanese pediatric patients with major depressive disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: RECRUITING